Universal Health Services, Inc.

UHS Healthcare Medical - Care Facilities NYSE

Back to Search

$192.53

$-4.44 (-2.25%)

Open: $194.92 | High: $194.92 | Low: $189.02 | Prev Close: $196.96

Market Cap: $12.24B

Volume: 333K | Avg: 765K

Last updated: March 06, 2026 at 06:05 PM
Investment Rating
A-

Buy

Overall Score: 80/100

Rating Breakdown:
DCF Score 4/5
80%
Buy
ROE Score 5/5
100%
Strong Buy
ROA Score 5/5
100%
Strong Buy
D/E Score 1/5
20%
Strong Sell
P/E Score 3/5
60%
Neutral
P/B Score 3/5
60%
Neutral
Add to Watchlist Add to Portfolio
Stock Score Analysis
C

Stock Score: 615

Comprehensive Quality Assessment

Component Breakdown:
Efficiency 50
Financial Health 55
Growth 85
Market Sentiment 20
Risk 40
Lower is better
Valuation 65
Momentum 0
View Full Stock Score Dashboard
Valuation Metrics
Valuation Ratios
P/E Ratio 8.33
P/B Ratio 1.68
P/S Ratio 0.70
EPS $23.10
Beta 1.26
Shares Outstanding 63.58M
Price Range & Moving Averages
52-Week High $246.33
52-Week Low $152.33
SMA 50 $214.58
SMA 200 $200.45
Dividend Information
Dividend Yield 0.42%
Annual Dividend $0.80
Earnings
Next Earnings April 28, 2026 09:00 PM ET
Financial Ratios
Margins
Gross Margin 70.0%
Operating Margin 11.5%
Net Margin 8.6%
Returns
ROE 21.0%
ROA 9.3%
Liquidity & Leverage
Debt/Equity 0.76
Current Ratio 1.05
Quick Ratio 0.98
Balance Sheet
Total Assets $15.96B
Total Liabilities $8.55B
Total Equity $7.28B
Cash $137.80M
Total Debt $5.51B
Net Debt $5.37B
Income Statement
Revenue $17.36B
Gross Profit $1.99B
Operating Income $1.99B
Net Income $1.49B
EBITDA $2.75B
Revenue/Share $273.11
Cash Flow
Operating CF $1.86B
CapEx $1.02B
Free Cash Flow $849.25M
Book Value/Share $116.53
Tangible Book/Share $52.58
Equity/Share $114.43
Technical Indicators
RSI (14) 14.85 Oversold
MACD
-4.78 Signal: -0.46
Volatility 48.29%
Trading Signal Oversold
Performance & Returns
Total Returns
1 Year -2.18%
Risk-Adjusted Returns
Sharpe Ratio -0.08 Poor
Volatility (Ann.) 31.71% Moderate
vs S&P 500 (SPY)
UHS (1Y) -2.18%
S&P 500 (1Y) +13.03%
Alpha (Excess Return) -15.22%
Risk-free rate: 4.5% (3-month US Treasury) • Based on 199 trading days
Sector Comparison (Healthcare)
Compared to 52 peers in Healthcare
Metric UHS Sector Avg Percentile
P/E Ratio 8.33 28.03 9%
P/B Ratio 1.68 -19.55 26%
ROE (%) 21.03% -9.69% 70%
Net Margin (%) 8.57% 9.33% 38%
Stock Score 615 542.0 81%
1Y Return (%) -2.18 % +8.35 % 40%
Percentile: 0% = worst in sector, 100% = best in sector
📊 Historical Price Analysis (Last 200 Days)

Loading chart...

Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
UHS $192.53 $199.16 $205.81 $215.66 $214.16 $200.50 14.85 -4.78 48.29% 234976 Strong Short Bearish Stack
Candlestick Patterns

There wasn't any recognizable pattern for the UHS stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
UHS First Trust Advisors LP Lowers Stock Holdings in Universal Health Services, Inc. $UHS Neutral defenseworld.net Read More
UHS Barclays PLC Reduces Stock Holdings in Universal Health Services, Inc. $UHS Neutral defenseworld.net Read More
UHS Universal Health Services, Inc. (UHS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Neutral seekingalpha.com Read More
UHS Talkspace Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Talkspace, Inc. - TALK Neutral businesswire.com Read More
UHS Can Universal Health's $835M Acquisition of Talkspace Accelerate Growth? Positive zacks.com Read More
Recent Insider Trading

No recent insider trading data available for UHS

Company Information

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

CEO Marc D. Miller
Employees 99300
Country US
IPO Date 1981-07-09
Exchange NYSE
Website https://uhs.com
Sector Healthcare
Industry Medical - Care Facilities
Similar Stocks (Healthcare - Medical - Care Facilities)
HCA

HCA Healthcare, Inc.

Price: $532.81
Change: -0.31%
Market Cap: $1191B
P/E: 18.79
Score: C (610)
View Details
SOLV

Solventum Corporation

Price: $69.41
Change: -1.94%
Market Cap: $1204B
P/E: 7.97
Score: D (547)
View Details
DVA

DaVita Inc.

Price: $150.76
Change: +0.55%
Market Cap: $1007B
P/E: 15.85
Score: D (575)
View Details
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.

Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.